Tickerover
Sign inStart free→
Healthcare

RVTY Stock Analysis

Revvity, Inc. · current price $128.80 (-0.75% today)

Top-tier setup — +13% 30-day momentum, 4/4 EPS beats. Caveat: trades 6.0% above analyst mean target. Stock is trading above the analyst mean target ($121) — limited consensus headroom.
★★★★★
Top Tier
📊

The six-pillar scorecard

Momentum
85
Trending up strong
price trend
Growth
25
Barely growing
sales & profit growth
Quality
92
High quality
profitability & balance sheet
Valuation
65
Fairly priced
is the price fair?
Sentiment
40
Mixed views
analyst & crowd mood
Risk
74
Low risk
volatility & drawdown

Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.

📉

The picture

What drove the scoreThe seven components contributing most, each read out of 100.
1-month momentum1-month momentum: 7575Relative strengthRelative strength: 100100Trend strengthTrend strength: 100100RSI zoneRSI zone: 8585GrowthGrowth: 4242Breakout proximityBreakout proximity: 7676Earnings qualityEarnings quality: 8484
Margin profileWhat survives each step down the income statement.
GrossGross: 55.0%55.0%OperatingOperating: 17.1%17.1%NetNet: 8.2%8.2%Free cash flowFree cash flow: 16.9%16.9%
EPS surpriseReported EPS against estimate, last four quarters.
2026-06: +15.9% vs estimate+16%2026-062026-03: +4.5% vs estimate+4%2026-032025-12: +7.8% vs estimate+8%2025-122025-09: +3.6% vs estimate+4%2025-09
👁

Hype Check

Reading RVTY’s price and volume history…

✓

The audit — what has to hold for this thesis

Checking the areas that decide this thesis…

AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.

🛡

Dilution Check

Reading RVTY’s filings…

📣

Latest earnings

LAST EARNINGS Revvity, Inc. (RVTY)

Latest earnings

EPS
$1.18 vs $1.14 est · +3.6% vs estimate BEAT
Stock reaction (1M)
+13.4%
Beat streak
4 of last 4 quarters
💰

Valuation

P/E
62.2×
Forward P/E
21.9×
PEG
0.80
Price / Sales
4.9×
Price / Book
2.0×
EV / EBITDA
19.1×
Analyst target
$121.07
Target range
$100.00 – $145.00
Implied upside
-6.0%
🩺

Financial health

Gross margin
55.0%
Operating margin
17.1%
Net margin
8.2%
FCF margin
16.9%
Return on equity
3.2%
Debt / equity
0.46
Revenue growth YoY
+1.3%
EPS growth YoY
+1.2%
📈

Technicals

$81.2252-week range$130.07
RSI (14)
70
50-day MA
$113.82
200-day MA
$101.46
ATR (14)
3.51
Beta
1.07
1-month return
+13.4%
🗓️

Earnings

QuarterEPSEst.SurpriseResult
2025-09-30$1.18$1.14+3.6%Beat
2025-12-31$1.70$1.58+7.8%Beat
2026-03-31$1.06$1.01+4.5%Beat
2026-06-30$1.41$1.22+15.9%Beat
Beat 4 of the last 4 quarters.
🏛️

Ownership & risk

Short % of float
0.09%
Dividend yield
0.22%
Beta
1.07
📰

Latest news on RVTY

🔗

Similar stocks in Healthcare

DXCMDexCom, Inc.CONConcentra Group Holdings Parent, ISHCSotera Health CompanyACADACADIA Pharmaceuticals Inc.BLFSBioLife Solutions, Inc.AAgilent Technologies, Inc.

View all Healthcare stocks →

❓

Frequently asked

What is RVTY's Quant Score?

Revvity, Inc. (RVTY) currently has a TickerMover Quant Score of 73/100, rated ★★★★★ Top Tier. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Revvity, Inc. (RVTY) a buy?

TickerMover does not give buy or sell recommendations. RVTY scores 73/100 (★★★★★ Top Tier) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is RVTY's score updated?

RVTY's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Tickerover

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.

Open the dashboard for RVTY →
TickerMover is a research tool, not financial advice. Quant Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.